» Articles » PMID: 22566567

Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium Tuberculosis

Overview
Journal J Immunol
Date 2012 May 9
PMID 22566567
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Although the protective role of type II IFN, or IFN-γ, against Mycobacterium tuberculosis has been established, the effects of type I IFNs are still unclear. One potential confounding factor is the overlap of function between the two signaling pathways. We used mice carrying null mutations in the type I IFNR, type II IFNR, or both and compared their immune responses to those of wild-type mice following aerosol infection with M. tuberculosis. We discovered that, in the absence of a response to IFN-γ, type I IFNs play a nonredundant protective role against tuberculosis. Mice unable to respond to both types of IFNs had more severe lung histopathology for similar bacterial loads and died significantly earlier than did mice with impaired IFN-γ signaling alone. We excluded a role for type I IFN in T cell recruitment, which was IFN-γ dependent, whereas both types of IFNs were required for optimal NK cell recruitment to the lungs. Type I IFN had a time-dependent influence on the composition of lung myeloid cell populations, in particular by limiting the abundance of M. tuberculosis-infected recruited macrophages after the onset of adaptive immunity. We confirmed that response to IFN-γ was essential to control intracellular mycobacterial growth, without any additional effect of type I IFN. Together, our results imply a model in which type I IFN limit the number of target cells that M. tuberculosis can infect in the lungs, whereas IFN-γ enhances their ability to restrict bacterial growth.

Citing Articles

Role of Type I Interferons during and HIV Infections.

Anes E, Azevedo-Pereira J, Pires D Biomolecules. 2024; 14(7).

PMID: 39062562 PMC: 11275242. DOI: 10.3390/biom14070848.


Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.

Zheng W, Chang I, Limberis J, Budzik J, Zha B, Howard Z PLoS Pathog. 2024; 20(5):e1012205.

PMID: 38701094 PMC: 11095722. DOI: 10.1371/journal.ppat.1012205.


A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.

Bobba S, Chauhan K, Akter S, Das S, Mittal E, Mathema B PLoS Pathog. 2024; 20(4):e1012137.

PMID: 38603763 PMC: 11037539. DOI: 10.1371/journal.ppat.1012137.


Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection.

Panda S, Morgan J, Cheng C, Saito M, Gilman R, Ciobanu N Nat Commun. 2024; 15(1):765.

PMID: 38278794 PMC: 10817963. DOI: 10.1038/s41467-024-45058-9.


Pathogenicity of Type I Interferons in .

Mundra A, Yegiazaryan A, Karsian H, Alsaigh D, Bonavida V, Frame M Int J Mol Sci. 2023; 24(4).

PMID: 36835324 PMC: 9965986. DOI: 10.3390/ijms24043919.


References
1.
Stark G, Kerr I, Williams B, Silverman R, Schreiber R . How cells respond to interferons. Annu Rev Biochem. 1998; 67:227-64. DOI: 10.1146/annurev.biochem.67.1.227. View

2.
Simmons D, Canaday D, Liu Y, Li Q, Huang A, Boom W . Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol. 2010; 185(4):2405-15. PMC: 2990778. DOI: 10.4049/jimmunol.0904005. View

3.
Nandi B, Behar S . Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med. 2011; 208(11):2251-62. PMC: 3201199. DOI: 10.1084/jem.20110919. View

4.
Gasser S, Raulet D . Activation and self-tolerance of natural killer cells. Immunol Rev. 2006; 214:130-42. DOI: 10.1111/j.1600-065X.2006.00460.x. View

5.
Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, Bonnefoy J . Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood. 2002; 101(1):143-50. DOI: 10.1182/blood-2002-04-1164. View